NeoGenomics prelim Q4 revenue slightly beats estimates, names insider as CFO
Overview
Cancer diagnostics firm's preliminary Q4 revenue rises 11%, slightly beating analyst expectations
Company anticipates full-year 2025 revenue growth of 10%
Company announces CFO transition, Abhishek Jain to succeed Jeff Sherman
Outlook
NeoGenomics anticipates preliminary Q4 2025 revenue of approximately $190 mln
Company expects prelim full-year 2025 revenue of approximately $727 mln
NeoGenomics aims to continue double-digit revenue growth trajectory
Result Drivers
CANCER TESTING PARTNER - NeoGenomics attributes revenue growth to its role as a preferred partner for cancer testing in community settings, offering a broad oncology test menu
BROAD TEST MENU - Co highlights its extensive oncology test offerings, including innovations in therapy selection and recurrence monitoring, as key to revenue growth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Slight Beat* | $190 mln | $188.26 mln (14 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Neogenomics Inc is $14.00, about 6.4% above its January 9 closing price of $13.16
The stock recently traded at 81 times the next 12-month earnings vs. a P/E of 49 three months ago
Press Release: ID:nBwy9YB3a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
Related Articles
Netflix After the Warner Deal: What Investors Should Know
TradingKey - For quite some time now, Netflix (NFLX) has been regarded as the premier subscription-based streaming service in the world, with a well-established history of growth through creative use of pricing power, developing hit programming, and relying very little on outside sources for licensi
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
